CLINICAL_TRIALS
trial_result
· 2019-03-01
Clinical Trial Update: A Study of LY2603618 in Combination With Gemcitabine in Participants With Solid Tumors [Phase 1]
Summary
Phase 1 clinical trial of LY2603618 in combination with gemcitabine for solid tumors; study completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Solid Tumors | Phase 1 | Status: COMPLETED | Results posted: 2019-03-01